MA vs PFE: Which Is the Better Buy?
Side-by-side comparison of Mastercard Incorporated and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Mastercard Incorporated · Financial Services
$498.66
+22.3% upside to fair value
High Conviction
Grade A-
VS
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
PFE has more upside to fair value
(+30.1%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MA |
PFE |
| Current Price |
$498.66 |
$26.91 |
| Fair Value Estimate |
$610.00 |
$35.00 |
| Upside to Fair Value |
+22.3%
|
+30.1%
|
| Market Cap |
$445.0B |
$153.0B |
| Forward P/E |
25.5x
|
9.5x
|
| EV / EBITDA |
22.4x
|
13.8x
|
| Price / Sales |
13.6x
|
2.4x
|
| Price / FCF |
26.0x
|
16.8x
|
| Revenue Growth YoY |
+16.4%
|
-1.6%
|
| Gross Margin |
83.4%
|
70.3%
|
| Operating Margin |
59.2%
|
24.7%
|
| Return on Equity |
198.4%
|
9.0%
|
| Dividend Yield |
0.65% |
6.4% |
| FCF Yield |
3.84%
|
5.9%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Mastercard operates one of the world's two dominant payment networks, processing over $9 trillion in gross dollar volume annually across 220+ countries. The business generates 83% gross margins and 46% net margins with zero credit risk because Mastercard never lends money, only collecting tolls on every transaction. Value-Added Services (analytics, fraud prevention, cybersecurity) now comprise 41…
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Accumulation Zones
| Metric |
MA |
PFE |
| Zone Low |
$460.00 |
$25.00 |
| Zone High |
$515.00 |
$29.00 |
| In Buy Zone? |
Yes
|
Yes
|